Strikingly, anti-PD-L1 therapy but not control IgG significantly delayed tumor growth of FibΔZeb1 in comparison with FibCtrl mice, eventually resulting in smaller FibΔZeb1 tumors at the endpoint (Fig. 5A,B). This evidence concerns the gene CD274 and neoplasm.